Proxy Votes Now

Home › Activist investors › Cannell Capital

Cannell Capital

Campaign activist. Positions and campaigns from Cannell Capital’s SEC filings. Updated November 21, 2026.

Filer entities
CANNELL CAPITAL LLC
SEC CIK
1058854 (CANNELL CAPITAL LLC)
SEC filings
Schedule 13D filings · 13F reports · soliciting material
Latest 13F
Quarter ended Sep 30, 2026, filed Nov 16, 2026: 29 US-listed positions reported; 9 of 1% or more of a company without a 13D are listed below.
9current positions
7new or changed in 90 days; 1 exited
0active campaigns
3campaigns on record

Active campaigns

No active campaign by this definition (see How to read this).

Current positions (9)

CompanyStakeSourceFirst disclosedLast changeSince previous filingFlagsStated intent
Network-1 Technologies, Inc. 6.03%1,380,636 shares 13F, quarter ended Sep 30, 2026filed Nov 16, 2026; % of shares outstanding as of Nov 2, 2026 Feb 13, 2015 Increased Nov 16, 2026 ▲ 0.45 pts Increased 13F: none stated
Verrica Pharmaceuticals Inc. 4.04%693,552 shares 13F, quarter ended Sep 30, 2026filed Nov 16, 2026; % of shares outstanding as of Jul 31, 2026 May 15, 2026 Decreased Nov 16, 2026 ▼ 0.53 pts Decreased 13F: none stated
Owlet, Inc. 3.61%1,054,481 shares 13F, quarter ended Sep 30, 2026filed Nov 16, 2026; % of shares outstanding as of Aug 6, 2026 Feb 17, 2026 Decreased Nov 16, 2026 ▼ 0.61 pts Decreased 13F: none stated
Shimmick Corporation 3.11%1,139,715 shares 13F, quarter ended Sep 30, 2026filed Nov 16, 2026; % of shares outstanding as of May 12, 2026 Aug 18, 2026 Increased Nov 16, 2026 ▲ 0.50 pts Increased 13F: none stated
Pure Cycle Corporation 1.95%468,822 shares 13F, quarter ended Sep 30, 2026filed Nov 16, 2026; % of shares outstanding as of Jul 6, 2026 Aug 18, 2026 Increased Nov 16, 2026 ▲ 0.64 pts Increased 13F: none stated
Build-A-Bear Workshop, Inc. 1.41%173,611 shares 13F, quarter ended Sep 30, 2026filed Nov 16, 2026; % of shares outstanding as of Sep 8, 2026 May 14, 2014 Increased Nov 16, 2026 ▲ 0.59 pts Increased 13F: none stated
Natural Gas Services Group, Inc. 1.03%133,056 shares 13F, quarter ended Sep 30, 2026filed Nov 16, 2026; % of shares outstanding as of Aug 7, 2026 May 15, 2025 Increased Nov 16, 2026 ▲ 0.08 pts Increased 13F: none stated
Global Indemnity Group, LLC 1.80%257,875 shares 13F, quarter ended Sep 30, 2026filed Nov 16, 2026; % of shares outstanding as of Mar 31, 2026 Nov 15, 2021 — 0.00 pts — 13F: none stated
MiMedx Group, Inc. 1.29%1,883,794 shares 13F, quarter ended Sep 30, 2026filed Nov 16, 2026; % of shares outstanding as of Oct 22, 2026 May 15, 2023 — ▲ 0.01 pts — 13F: none stated

Stake: the latest 13D’s percent of the class (the largest single reporting person’s, as filed), or for a 13F the reported shares as a percent of the company’s shares outstanding on the date shown. Since previous filing: the change in percentage points against the investor’s previous 13D on the company, or its previous 13F.

Campaigns are compiled from SEC filings (13D, proxy contest filings and settlement 8-Ks); campaigns run without SEC filings, e.g. by public letter below the 5% threshold, may not appear.

Past campaigns (3)
CompanyOutcome or last statusDateFirst filingHighest stageFilingsMeeting / votes
Lee Enterprises, Inc Exempt solicitation (shareholder proposal) Feb 4, 2019 Dec 27, 2018 Exempt solicitation filed (PX14A6G) latest (4) —
Envivio IncBoard seats Outcome not captured (no campaign filing in the last 12 months) May 5, 2015 Jan 16, 2015 Proxy contest filed (preliminary proxy) latest (2) —
Procera Networks, Inc. Outcome not captured (no campaign filing in the last 12 months) Feb 26, 2015 Jan 15, 2015 Soliciting material filed latest (3) —
Past positions (3)
CompanyLast stakeSourceOutcomeDate
Chegg, Inc. 8.10% 13F, quarter ended Jun 30, 2026filed Aug 18, 2026; % of shares outstanding as of Aug 3, 2026 Not in the latest 13F Nov 16, 2026
Sportsman'S Warehouse Holdings, Inc. 10.0% Schedule 13D/A, filed Sep 18, 2023 Not in the 13F for the quarter ended Mar 31, 2025 May 15, 2025
Neuronetics, Inc. 8.4% Schedule 13D/A, filed Aug 17, 2023 Not in the 13F for the quarter ended Dec 31, 2024 Feb 13, 2025

How large managers voted in Cannell Capital’s proxy contests (meetings since July 2023)

Fund votes come from Form N-PX filings, which this site holds from July 1, 2023 (meetings through June 30, 2026; later meetings appear when the managers file their next N-PX); earlier contests and campaigns that settled before a vote are listed under the activist’s campaigns.

No proxy contest has gone to a vote since July 1, 2023.

Track record

How each campaign on record ended, as read from the filings: settlements disclosed in the company’s 8-K or the investor’s 13D, contested votes (8-K Item 5.07), withdrawals and 13D amendments below 5%.

3No outcome in the filings read
Outcome of each campaign (3)
CompanyOutcomeDetailDateFirst filing
Lee Enterprises, Inc No outcome in the filings read — Apr 11, 2022 Dec 27, 2018
Envivio Inc No outcome in the filings read — May 5, 2015 Jan 16, 2015
Procera Networks, Inc. No outcome in the filings read — Feb 26, 2015 Jan 15, 2015

Share price after the first 13D

The change in the company’s closing share price from the first trading day on or before the investor’s first Schedule 13D to the latest close, and to 6 and 12 months after it, beside the S&P 500 (SPY) over the same dates. This is a price change after a filing date: it is not attributed to the investor, and it is not the investor’s return. Coverage: 0 of 2 13D positions have prices (the site’s daily price history starts November 10, 2025, and covers only listed tickers it tracks).

Other disclosed holders around the same time

Filings by other activists on this list (their first 13D or 13F on the company) and by other holders of 5% or more (Schedule 13D or 13G) dated within 180 days of Cannell Capital’s first disclosure in the same company. They are listed together by date only; nothing here says the holders act together.

Pure Cycle Corporation · Cannell Capital first disclosed Aug 18, 2026 · 1 other filing
HolderFormDateStake
Magnolia Capital Fund, LP Schedule 13G Aug 14, 2026 7.5%
Verrica Pharmaceuticals Inc. · Cannell Capital first disclosed May 15, 2026 · 1 other filing
HolderFormDateStake
Caligan Partners Schedule 13D Nov 24, 2025 10.0%
Chegg, Inc. · Cannell Capital first disclosed Feb 17, 2026 · 2 other filings
HolderFormDateStake
The Vanguard Group Schedule 13G Oct 30, 2025 5.0%
Galloway Capital Partners, LLC Schedule 13D Apr 8, 2026 5.4%
Natural Gas Services Group, Inc. · Cannell Capital first disclosed May 15, 2025 · 2 other filings
HolderFormDateStake
Mill Road Capital Schedule 13D Nov 25, 2024 4.3%
Taylor Stephen Charles Schedule 13D Nov 25, 2024 —
Sportsman'S Warehouse Holdings, Inc. · Cannell Capital first disclosed Jun 28, 2023 · 1 other filing
HolderFormDateStake
GAMCO / Gabelli Schedule 13D Sep 8, 2023 —
MiMedx Group, Inc. · Cannell Capital first disclosed May 15, 2023 · 1 other filing
HolderFormDateStake
Nantahala Capital 13F Feb 14, 2023 4.7%

How to read this

Flags (last 90 days)
New first disclosed in the last 90 days. Increased / Decreased shares up or down in a 13D/A or 13F filed in that time. Below 5% a 13D/A reported less than 5%, the reporting threshold. Exited a 13D/A reported no shares, or the investor’s 13F no longer lists a company it listed before.
Active campaign
A contested meeting at which the investor is soliciting proxies is still to be held; or in the last 12 months it filed a proxy-contest document (PREC14A, DEFC14A or DFAN14A soliciting material), stated in a 13D that it nominated directors, filed a letter or presentation to the board or shareholders, or stated public demands in a 13D — and no settlement, withdrawal, contested vote or 13D below 5% is dated on or after the latest such filing. Status is the furthest step since then: Public demands in a 13D < Public letter or soliciting material < Nominations made < Proxy contest filed.
Sources and limits
SEC EDGAR only. 13D data covers filings since June 2023; 13F reports are quarterly and filed up to 45 days after the quarter, and do not show swaps, most options or non-US holdings. Settlements are cooperation agreements disclosed in the company’s 8-K or stated in the investor’s 13D; board seats are read from the 8-K. Text marked Summary of the filing is checked against the filing, whose words are quoted beside it. Nothing on this page predicts what the investor will do.